Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.044501 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Takashi Hiruma und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Electrocardiography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In patients with hypertrophic cardiomyopathy (HCM), genetic testing is crucial for cascade screening and risk stratification. However, it remains limited by financial and logistical constraints, necessitating prioritization. The Mayo HCM Genotype Predictor Score, based on clinical and echocardiographic variables, estimates genotype positivity with acceptable performance. Although sarcomeric variants are also associated with electrophysiological abnormalities, ECG parameters were not incorporated into this model. This study aimed to enhance genotype prediction in HCM by integrating ECG parameters.
Methods
We retrospectively analyzed 466 patients with HCM from a Japanese multicenter cohort. Genotype positivity was defined as harboring pathogenic/likely pathogenic variants in sarcomere‐encoding genes. Candidate ECG variables were selected via multivariable logistic regression with bootstrap aggregation. A point‐based novel score was developed and internally validated using cross‐validation. Model performance was assessed by the area under the receiver operating characteristic curve and Akaike’s information criterion.
Results
Genotype‐positive patients (30.3%) more frequently exhibited atrial fibrillation, intraventricular conduction disturbance, lower prevalence of high voltage, and abnormal T‐wave inversion in precordial leads than genotype‐negative patients and thus were incorporated into the novel Mayo‐ECG score. This score stratified genotype positivity from 7.1% (score ≤−1) to 91.4% (score ≥4), and its discriminative performance (area under the receiver operating characteristic curve, 0.81 [95% CI, 0.77–0.85]) outperformed the Mayo score (area under the receiver operating characteristic curve, 0.76 [95% CI, 0.71–0.81]; P =0.005) with better overall model fit (Akaike’s information criterion: 439 versus 479). Internal validation yielded consistent results with good calibration.
Conclusions
The Mayo‐ECG improves genotype prediction, outperforming the conventional model. Given its simplicity, this model has the potential to prioritize genetic testing in HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan.
- Department of Frontier Cardiovascular Science The University of Tokyo Graduate School of Medicine Tokyo Japan.
- Department of Cardiology and Geriatrics, Kochi Medical School Kochi University Kochi Japan.
- Department of Cardiology Sakakibara Heart Institute Tokyo Japan.
- Department of Medical Genetics Sakakibara Heart Institute Tokyo Japan.
- Department of Cardiology Tokyo Women's Medical University Tokyo Japan.
ORCID-Profile: Takashi Hiruma, Shunsuke Inoue, Zhehao Dai, Seitaro Nomura, Toru Kubo, Kenta Sugiura, Yuki Izumi, Hiroko Morisaki, Shouji Matsushima, Keiko Goto, Masahiro Wanezaki, Ryo Abe, Takanobu Yamada, Manami Katoh, Toshiyuki Ko, Masamichi Ito, Junichi Ishida, Eisuke Amiya, Masaru Hatano, Norifumi Takeda, Masafumi Watanabe, Tohru Minamino, Junichi Yamaguchi, Takayuki Inomata, Morimasa Takayama, Mitsuaki Isobe, Hiroaki Kitaoka, Norihiko Takeda, Issei Komuro
Zitieren
APA
Hiruma, T., Inoue, S., Dai, Z., Nomura, S., Kubo, T., Sugiura, K., Izumi, Y., Morisaki, H., Suzuki, A., Kashimura, T., Matsushima, S., Goto, K., Wanezaki, M., Abe, R., Yamada, T., Tobita, T., Katoh, M., Ko, T., Ito, M., …, & Komuro, I. (2026). Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044501
Vancouver
Hiruma T, Inoue S, Dai Z, Nomura S, Kubo T, Sugiura K, et al. Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044501
BibTeX
@article{Hiruma2026,
author = {Hiruma, Takashi and Inoue, Shunsuke and Dai, Zhehao and Nomura, Seitaro and Kubo, Toru and Sugiura, Kenta and Izumi, Yuki and Morisaki, Hiroko and Suzuki, Atsushi and Kashimura, Takeshi and Matsushima, Shouji and Goto, Keiko and Wanezaki, Masahiro and Abe, Ryo and Yamada, Takanobu and Tobita, Takashige and Katoh, Manami and Ko, Toshiyuki and Ito, Masamichi and Ishida, Junichi and Amiya, Eisuke and Hatano, Masaru and Takeda, Norifumi and Morita, Hiroyuki and Watanabe, Masafumi and Minamino, Tohru and Yamaguchi, Junichi and Inomata, Takayuki and Tsutsui, Hiroyuki and Takayama, Morimasa and Isobe, Mitsuaki and Kitaoka, Hiroaki and Takeda, Norihiko and Komuro, Issei},
title = {Integrating ECG Into the Mayo Score Enhances Genotype Prediction in Hypertrophic Cardiomyopathy},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.044501}
}
EUVIMED